Bioton SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioton SA with three other
pharmaceutical manufacturers in Europe:
sales of 87.27 million Euro [US$119.54 million]
of which 100%
was Drug Discovery & Development),
Cathay International Holdings Limited
of the United Kingdom
(£68.62 million [US$112.12 million]
of which 86%
was Lansen Group), and
based in Latvia
(82.69 million Latvian Lats [US$161.19 million]
During the year ended December of 2012, sales at
Bioton SA were 406.30 million Polish New Zlotys (US$133.00 million).
increase of 40.6%
versus 2011, when the company's sales were 288.98 million Polish New Zlotys.
Sales of Copernicus saw an increase
that was more than double the company's growth rate: sales were up
4,307.3% in 2012, from
41,000.00 Polish New Zlotys to 1.81 million Polish New Zlotys.
Not all segments of Bioton SA experienced an increase in sales in 2012:
sales of Pharmatex fell 5.4% to 36.60 million Polish New Zlotys.